Nanosonics Ltd 2025 SR
The report highlights Nanosonics' progress in FY25, focusing on its mission to transform medical device reprocessing and improve patient safety. Key achievements include protecting over 28 million patients from cross-contamination and transitioning to 100% renewable energy at its two main sites, resulting in a 56% reduction in Scope 1 and 2 emissions. The company also advanced its product pipeline with the launch of trophon3 and progress toward the CORIS platform for endoscope cleaning. Additionally, Nanosonics maintained 100% compliance with its Code of Conduct training and improved gender diversity, with women now representing 42.5% of the Board.
Company: Nanosonics Ltd
Sector: Health Care
Country: Australia
Year: 2025
Type: SR
Pages: 13
Nanosonics Ltd
Sustainability Report
The report highlights Nanosonics' progress in FY25, focusing on its mission to transform medical device reprocessing and improve patient safety. Key achievements include protecting over 28 million patients from cross-contamination and transitioning to 100% renewable energy at its two main sites, resulting in a 56% reduction in Scope 1 and 2 emissions. The company also advanced its product pipeline with the launch of trophon3 and progress toward the CORIS platform for endoscope cleaning. Additionally, Nanosonics maintained 100% compliance with its Code of Conduct training and improved gender diversity, with women now representing 42.5% of the Board.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jul 1, 2024 - Jun 30, 2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Employees